Sequenom Inc. to Present at 7th Annual Needham & Company Biotechnology & Medical Technology Conference

SAN DIEGO--(BUSINESS WIRE)--Sequenom, Inc. (NASDAQ: SQNM), a leading provider of genetic analysis solutions, today announced that Harry Stylli, Ph.D., President and Chief Executive Officer, is scheduled to present at the 7th Annual Needham & Company Biotechnology & Medical Technology Conference on Thursday, June 12th at 11:00 a.m. Eastern time (8:00 a.m. Pacific time). The conference is being held at The New York Palace Hotel in New York City.
MORE ON THIS TOPIC